
Jeprifa 400mg Tablet
Marketer
Syntonic Lifesciences
Salt Composition
Rifaximin (400mg)
Overview Jeprifa 400mg Tablet
Cefixime 400mg tablets combat hepatic encephalopathy, a liver-related condition where toxins build up in the bloodstream, potentially causing brain damage. This antibiotic also treats bacterial diarrhea. Its mechanism involves eliminating and inhibiting the proliferation of harmful gut bacteria. Administration can be independent or alongside other medications, with or without food, ideally at a consistent time daily. Dosage and treatment length should follow your physician's instructions. Maintaining a regular schedule maximizes efficacy; premature discontinuation risks infection recurrence and treatment resistance. Potential side effects, including nausea, vomiting, headache, dizziness, skin rashes, arthralgia, and depression, are generally transient, resolving as the body adapts. Persistent or bothersome side effects warrant medical consultation. A harmless, temporary reddish urine discoloration is a possible occurrence. Prior to commencing treatment, inform your doctor of pregnancy, breastfeeding, pre-existing liver, kidney, or heart conditions, or any medication allergies.
Uses of Jeprifa 400mg Tablet
Managing hepatic encephalopathy and infectious diarrhea.
Major Benefits of Jeprifa 400mg Tablet:
Administer Jeprifa 400mg Tablet as prescribed by your physician, ingesting the entire tablet without chewing, crushing, or dividing it. Consumption may occur with or without food, though consistent timing is recommended.
Common Side effects of Jeprifa 400mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Ascites (accumulation of fluid in the abdominal cavity)
- Fatigue
- Depression
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Joint pain
- Rash
- Muscle pain
How to use Jeprifa 400mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 400mg Jeprifa tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is permissible, consistent timing is recommended for optimal results.
How Jeprifa 400mg Tablet works:
A 400mg dose of Jeprifa tablets provides antibiotic action, targeting and eliminating ammonia-generating bacteria within the gastrointestinal system. This effectively manages infections and alleviates hepatic encephalopathy symptoms such as restlessness, cognitive impairment, and neuromuscular dysfunction. Furthermore, this treatment contributes to a decreased likelihood of subsequent hepatic encephalopathy episodes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Jeprifa 400mg Tablet may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Jeprifa 400mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingSAFE IF PRESCRIBED
Using Jeprifa 400mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Jeprifa 400mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Jeprifa 400mg Tablets in individuals with kidney disease is likely safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverCAUTION
For patients with severe hepatic impairment, administering Jeprifa 400mg tablets requires careful consideration. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Jeprifa 400mg Tablet :
Should you forget a Jeprifa 400mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jeprifa 400mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Rifamycin-based compounds |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Rifamycin Antibiotics: RNA Polymerase Inhibitors |
